906
Views
87
CrossRef citations to date
0
Altmetric
Original Articles

Antiproliferative and proapoptotic activity of Turkish propolis on human lung cancer cell line

, , , , , , , & show all
Pages 165-172 | Received 15 Jun 2015, Accepted 29 Oct 2015, Published online: 23 Dec 2015

References

  • Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol 17, 2941–2953, 1999.
  • Alwan A, MacLean DR, Riley LM, d'Espaignet ET, Mathers CD, et al:. Chronic diseases: chronic diseases and development 5 monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 376, 1861–1868, 2010.
  • Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144, 646–674, 2011.
  • Ford DW, Koch KA, Ray DE, and Selecky PA: Palliative and end-of-life care in lung cancer. Chest 143, e498S–e512S, 2013.
  • Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, and Capella G: Recent advances in cancer therapy: an overview. Curr Pharm Des 16, 3–10, 2010.
  • Fulda S: Modulation of apoptosis by natural products for cancer therapy. Planta Med 76, 1075–1079, 2010.
  • Watanabe MAE, Amarante MK, Conti BJ, and Sforcin JM: Cytotoxic constituents of propolis inducing anticancer effects: A review. J Pharm Pharmacol 63, 1378–1386, 2011.
  • Bankova V, Popova M, and Trusheva B: Propolis volatile compounds: chemical diversity and biological activity: a review. Chem Cent J 8, 28, 2014.
  • Aliyazicioglu Y, Demir S, Turan I, Cakiroglu TN, Akalin I, et al.: Preventive and protective effects of Turkish propolis on H2O2-induced DNA damage in foreskin fibroblast cell lines. Acta Biol Hung 62, 388–396, 2011.
  • Bankova V, Popova M, and Trusheva B: Propolis volatile compounds: Chemical diversity and biological activity: A review. Chem Cent J 8, 1–28, 2014.
  • Sawicka D, Car H, Borawska MH, and Niklinski J: The anticancer activity of propolis. Folia Histochem Cyto 50, 25–37, 2012.
  • Vit P, Huq F, Barth OM, Campo M, Pérez-Pérez EM, et al.: Use of propolis in cancer research. Br J Med Med Res 8(2), 88–109, 2015.
  • Gunduz C, Biray C, Kosova B, Yilmaz B, Eroglu Z, et al.: Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity. Leuk Res 29, 1343–1346, 2005.
  • Vatansever SH, Sorkun K, Gurhan SID, Ozdal Kurt F, Turkoz E, et al.: Propolis from Turkey induces apoptosis through activating caspases in human breast carcinoma cell lines. Acta Histochem 112, 546–556, 2010.
  • Barlak Y, Deger O, Colak M, Karataylı SC, Bozdayı AM, et al.: Effect of Turkish propolis extracts on proteome of prostate cancer cell line. Proteome Sci 9, 74, 2011.
  • Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, et al.: Treatment options for small cell lung cancer: do we have more choice? Br J Cancer 102, 629–638, 2010.
  • Turan I, Demir S, Misir S, Kilinc K, Mentese A, et al.: Cytotoxic effect of Turkish propolis on liver, colon, breast, cervix and prostate cancer cell lines. Trop J Pharm Res 14, 777–782, 2015.
  • Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55–63, 1983.
  • Russo A, Cardile V, Sanchez F, Troncoso N, Vanella A, et al.: Chilean propolis: antioxidant activity and antiproliferative action in human tumor cell lines. Life Sci 76, 545–558, 2004.
  • Xuan H, Li Z, Yan H, Sang Q, Wang K, et al.: Antitumor activity of Chinese propolis in human breast cancer MCF-7 and MDA-MB-231 cells. Evid Based Complement Alternat Med, Article ID 280120, 2014.
  • Shamsuzzaman, Dar AM, Yaseen Z, Alam K, Hussain A, et al.: Steroidal pyrimidines: synthesis, characterization, molecular docking studies with DNA and in vitro cytotoxicity. J Mol Struct 1045, 62–71, 2013.
  • Frion-Herrera Y, Diaz-Garcia A, Rodriguez-Sanchez H, Ruiz-Fuentes J, Monzote-Fidalgo L, et al.: Cytotoxic effect of Cuban propolis extracts against tumor cells lines. Am J Essen Oils Nat Prod 1, 112–117, 2013.
  • Luo J, Solimini NL, and Elledge SJ: Principles of cancer therapy: Oncogene and non-oncogene addiction. Cell 136, 823–837, 2009.
  • Premratanachai P and Chanchao C: Review of the anticancer activities of bee products. Asian Pac J Trop Biomed 4, 337–344, 2014.
  • Sforcin JM and Bankova V: Propolis: is there a potential for the development of new drugs? J Ethnopharmacol 133, 253–260, 2011.
  • Gomez-Caravaca AM, Gomez-Romero M, Arraez-Roman D, Segura-Carretero A, and Fernandez-Gutierrez A: Advances in the analysis of phenolic compounds in products derived from bees. J Pharmaceut Biomed 41, 1220–1234, 2006.
  • Valente MJ, Baltazar AF, Henrique R, Estevinho L, and Carvalho M: Biological activities of Portuguese propolis: Protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro. Food Chem Toxicol 49, 86–92, 2011.
  • Teerasripreecha D, Phuwapraisirisan P, Puthong S, Kimura K, Okuyama M, et al.: In vitro antiproliferative/cytotoxic activity on cancer cell lines of a cardanol and a cardol enriched from Thai Apis mellifera propolis. BMC Complement Altern Med 12, 27, 2012.
  • Da Silva Frozza CO, Celi Garcia CS, Gambato G, Oliveira de Souza MD, Salvador M, et al.: Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis. Food ChemToxicol 52, 137–142, 2013.
  • Galati G and O'Brien PJ: Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37, 287–303, 2004.
  • Kouidhi B, Zmantar T, and Bakhrouf A: Anti-cariogenic and anti-biofilms activity of Tunisian propolis extract and its potential protective effect against cancer cells proliferation. Anaerobe 16, 566–571, 2010.
  • Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, and Cascante M: Targeting cell cycle regulation in cancer therapy. Pharm Therap 138, 255–271, 2013.
  • Sankari SL, Masthan KMK, Babu NA, Bhattacharjee T, and Elumalai M: Apoptosis in cancer: An update. Asian Pac J Cancer Prev 13, 4873–4878, 2012.
  • Akao Y, Maruyama H, Matsumoto K, Ohguchi K, Nishizawa K, et al.: Cell growth inhibitory effect of cinnamic acid derivatives from propolis on human tumor cell lines. Biol Pharm Bull 26, 1057–1059, 2003.
  • Motomura M, Kwon KM, Suh SJ, Lee YC, Kim YK, et al.: Propolis induces cell cycle arrest and apoptosis in human leukemic U937 cells through Bcl-2/Bax regulation. Environ Toxicol Pharm 26, 61–67, 2008.
  • Szliszka E, Czuba ZP, Domino M, Mazur B, Zydowicz G, et al.: Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 14, 738–754, 2009.
  • Gorman AM, Healy SJM, Jager R, and Samali A: Stress management at the ER: Regulators of ER stress-induced apoptosis. Pharm Therap 134, 306–316, 2012.
  • Li Y, Guo Y, Tang J, Jiang J, and Chen Z: New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim Biophys Sin 46, 629–640, 2014.
  • Kamiya T, Nishihara H, Hara H, and Adachi T: Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J Agr Food Chem 60, 11065–11070, 2012.
  • Chou CC, Yang JS, Lu HF, Ip SW, Lo C, et al.: Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33, 1181–1191, 2010.
  • Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, et al.: Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol Res 160, 189–195, 2005.
  • Hadi SM, Asad SF, Singh S, and Ahmad A: Putative mechanism for anticancer and apoptosis-inducing properties of plant derived polyphenolic compounds. IUBMB Life 50, 167–171, 2000.
  • Lee WL, Huang JY, and Shyur LF: Phytoagents for cancer management: Regulation of nucleic acid oxidation, ROS, and related mechanisms. Oxid Med Cell Longev, Article ID 925804, 2013.
  • Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC, et al.: Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol 66, 2281–2289, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.